Zusammenfassung
Brustkrebs ist hinsichtlich Inzidenz und Mortalität die häufigste bösartige Neubildung bei Frauen weltweit. In Deutschland erkranken jährlich ca. 46 000 Frauen neu an Brustkrebs, 18 000 Frauen versterben daran. Bisher gibt es nur wenige Informationen, ob sich die epidemiologischen und klinischen Aspekte des Brustkrebses bei deutschen Frauen und bei Frauen aus anderen ethnischen bzw. nationalen Gruppen in Deutschland unterscheiden. Entsprechende Unterschiede zwischen Migrantinnen und Allgemeinbevölkerung könnten Hinweise auf Krankheitsursachen und Unterschiede in der Zugänglichkeit medizinischer Versorgung geben. In diesem Beitrag stellen wir erste epidemiologische Erkenntnisse zu Brustkrebs bei türkischen Frauen vor und zeigen auf, welche diesbezüglichen Forschungsfragen in Zukunft zu bearbeiten sind.
Abstract
Breast cancer is the leading cause of cancer death and morbidity among women worldwide. In Germany an estimated 46 000 women are diagnosed with breast cancer every year, and 18 000 die of the diesease. So far, limited information is available on possible epidemiological and clinical differences between women of German origin and other ethnic or national groups in Germany. Such differences between migrants and the general population could hint to underlying causes of disease and to differential access to medical care. In this paper we present epidemiological information on breast cancer among Turkish women in Germany and describe a future research agenda adressing these questions.
Schlüsselwörter
Brustkrebs - Migranten - Deutschland - Epidemiologie
Key words
Breast cancer - migration - Germany - epidemiology
Literatur
-
1
Baquet C R, Commiskey P.
Socioeconomic factors and breast carcinoma in multicultural women.
Cancer.
2000;
88
1256-1264
-
2
Bollini P, Siem H.
No real progress towards equity: health of migrants and ethnic minorities on the eve of the year 2000.
Soc Sci Med.
1995;
41
819-828
-
3 Breslow N, Day N. Statistical methods in cancer research - The analysis of cohort studies. IARC, Lyon 1987
-
4
Chakraborty R, Kamboh M I, Ferrell R E.
‘Unique’ alleles in admixed populations: a strategy for determining ‘hereditary’ population differences of disease frequencies.
Ethn Dis.
1991;
1
245-256
-
5
Dano H, Andersen O, Ewertz M, Petersen J H, Lynge E.
Socioeconomic status and breast cancer in Denmark.
Int J Epidemiol.
2003;
32
218-224
-
6
Eley J W, Hill H A, Chen V W. et al .
Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study.
JAMA.
1994;
272
947-954
-
7 Ferlay J, Bray P, Pisani P, Parkin D M. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. (IARC Cancer Base No. 5; Version 1.0). IARC, Lyon 2001
-
8
Fidaner C, Eser S Y, Parkin D M.
Incidence in Izmir in 1993-1994: First results from Izmir Cancer Registry.
Eur J Cancer.
2001;
37
83-92
-
9
Haenszel W, Kurihara M.
Studies of Japanese migrants I. Mortality from cancer and other diseases among Japanese in the United States.
J Natl Cancer Inst.
1968;
40
43-68
-
10 Henderson B E, Pike M C, Bernstein L, Ross R K. Breast cancer. In: Schottenfeld D, Fraumeni JF Jr (Hrsg). Cancer epidemiology and prevention. 2nd ed. Oxford University Press, New York 1996; 1022-1039
-
11
Hunter C P.
Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations.
Cancer.
2000;
88
1193-1202
-
12
Jatoi I, Becher H, Leake C R.
Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare System.
Cancer.
2003;
98
894-899
-
13
McCredie M.
Cancer epidemiology in migrant populations.
Recent Results Cancer Res.
1998;
154
298-305
-
14
McTiernan A, Kooperberg C, White E. et al .
Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study.
JAMA.
2003;
290
1331-1336
-
15
Morabia A, Costanza M C.
International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
Am J Epidemiol.
1998;
148
1195-1205
-
16
Newman L A, Mason J, Cote D, Vin Y, Carolin K, Bouwman D, Colditz G A.
African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10 000 African-American and 40 000 white American patients with carcinoma of the breast.
Cancer.
2002;
94
2844-2854
-
17
Parkin D M, Khlat M.
Studies of cancer in migrants: rationale and methodology.
Eur J Cancer.
1996;
32 A
761-771
-
18 Razum O. Gesundheitsberichterstattung für Migrantinnen und Migranten: Möglichkeiten und Grenzen. In: Borde T, David M (Hrsg). Gut versorgt? Migrantinnen und Migranten im Gesundheits- und Sozialwesen. Mabuse, Frankfurt/M. 2003; 265-273
-
19
Razum O, Zeeb H.
Epidemiologische Studien unter ausländischen Staatsbürgern in Deutschland - Notwendigkeit und Beschränkungen.
Gesundheitswesen.
1998;
60
283-286
-
20
Razum O, Zeeb H, Akgun S.
How useful is a name-based algorithm in health research among Turkish migrants in Germany?.
Trop Med Int Health.
2001;
6
654-661
-
21
Razum O, Zeeb H, Beck K, Becher H, Ziegler H, Stegmaier C.
Combining a name algorithm with a capture-recapture method to retrieve cases of Turkish descent in a German population-based cancer registry.
Eur J Cancer.
2000;
36
2380-2384
-
22
Sasco A J.
Epidemiology of breast cancer: an environmental disease?.
APMIS.
2001;
109
321-332
-
23
Stanford J L, Herrinton L J, Schwartz S M, Weiss N S.
Breast cancer incidence in Asian migrants to the United States and their descendants.
Epidemiology.
1995;
6
181-183
-
24 World Health Organization, International Agency for Research on Cancer .World cancer report. IARC, Lyon 2003
-
25
Yang D, Bernstein L, Wu A H.
Physical activity and breast cancer risk among Asian-American women in Los Angeles: a case-control study.
Cancer.
2003;
97
2565-2575
-
26
Zeeb H, Razum O, Blettner M, Stegmaier C.
Transition in cancer patterns among Turks residing in Germany.
Eur J Cancer.
2002;
38
705-711
PD Dr. Hajo Zeeb
AG Epidemiologie und Med. Statistik
Fakultät für Gesundheitswissenschaften
Universität Bielefeld
Postfach 10 01 31
33501 Bielefeld
Email: Hajo.Zeeb@uni-bielefeld.de
